MARKET

TENX

TENX

Tenax Therapeut
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5640
-0.0077
-1.35%
Closed 16:00 04/01 EDT
OPEN
0.5800
PREV CLOSE
0.5717
HIGH
0.5980
LOW
0.5500
VOLUME
43.14K
TURNOVER
--
52 WEEK HIGH
2.160
52 WEEK LOW
0.2500
MARKET CAP
4.29M
P/E (TTM)
-0.0953
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TENX stock price target is 4.225 with a high estimate of 4.450 and a low estimate of 4.000.

EPS

TENX News

More
  • Companies Like Tenax Therapeutics (NASDAQ:TENX) Can Be Considered Quite Risky
  • Simply Wall St. · 03/19 15:16
  • Tenax Therapeutics Filing Shows Registration For 750K Common Stock Offering
  • Benzinga · 03/13 12:16
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52
  • Tenax down 43% on equity offering
  • Seeking Alpha - Article · 03/12 15:02

Industry

Biotechnology & Medical Research
-4.52%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About TENX

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
More

Webull offers kinds of Tenax Therapeutics Inc stock information, including NASDAQ:TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions.